Poniard Pharmaceuticals, Inc. (PARD)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Oct 31, 2025, 4:00 PM EDT
Poniard Pharmaceuticals Statistics
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
PARD has 1.50 million shares outstanding.
| Current Share Class | 1.50M |
| Shares Outstanding | 1.50M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.65% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.76, with a Debt / Equity ratio of 0.53.
| Current Ratio | 0.76 |
| Quick Ratio | 0.67 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.16 |
| Interest Coverage | -26.71 |
Financial Efficiency
Return on equity (ROE) is -210.37% and return on invested capital (ROIC) is -57.06%.
| Return on Equity (ROE) | -210.37% |
| Return on Assets (ROA) | -46.03% |
| Return on Invested Capital (ROIC) | -57.06% |
| Return on Capital Employed (ROCE) | -300.95% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -2.03M |
| Employee Count | 8 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -70.54 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 69.33 |
| Average Volume (20 Days) | 235 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.21 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -14.32M |
| Pretax Income | -16.04M |
| Net Income | -16.23M |
| EBITDA | -13.04M |
| EBIT | -14.32M |
| Earnings Per Share (EPS) | -3.79 |
Balance Sheet
The company has 1.98 million in cash and 1.64 million in debt, giving a net cash position of 344,000 or 0.23 per share.
| Cash & Cash Equivalents | 1.98M |
| Total Debt | 1.64M |
| Net Cash | 344,000 |
| Net Cash Per Share | 0.23 |
| Equity (Book Value) | 3.12M |
| Book Value Per Share | 2.08 |
| Working Capital | -727,000 |
Cash Flow
In the last 12 months, operating cash flow was -10.46 million and capital expenditures -9,000, giving a free cash flow of -10.47 million.
| Operating Cash Flow | -10.46M |
| Capital Expenditures | -9,000 |
| Free Cash Flow | -10.47M |
| FCF Per Share | -6.98 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PARD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -289.32% |
| Shareholder Yield | -289.32% |
| Earnings Yield | -10,822,666.67% |
| FCF Yield | -6,977,333.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 23, 2011. It was a reverse split with a ratio of 0.025.
| Last Split Date | Nov 23, 2011 |
| Split Type | Reverse |
| Split Ratio | 0.025 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |